Most people can return to normal activities after treatment, although some temporary redness, sensitivity, or small marks at needle sites may occur
Key players today include Mounjaro (tirzepatide) a dual-agonist of GLP-1 and GIP receptors and coming soon, Retatrutide a triple-receptor agonist (GLP-1, GIP and glucagon) that has shown even stronger early results
Responsible use means taking proactive steps to minimize risk, ensure purity, and follow best practices for dosing and administration
We next investigated whether altered insulin production in Tmprss2 / mice led to enhanced local insulin signaling in the intestine
What You Should Discuss With Your Doctor Before starting a GLP-1, have a detailed conversation with your healthcare provider
10 Best Longevity and Anti-Ageing Supplements Discover the top 10 supplements to support your health and longevity